2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on Recent FDA Approvals for Adjuvant HER2+ EBC: Neratinib, Pertuzumab & T-DM-1 - How Much Benefit Can Be Expected?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Kevin Kalinsky
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Kevin Kalinsky
Login to view comments.
Click here to Login
